Docusign (NASDAQ: DOCU) stock soared to a peak of $310 in 2021 on the back of an incredible spike in demand for the company's ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Is ENPH stock a worthwhile purchase following such a considerable drop? This steep decrease for Enphase Energy stands out ...

DocuSign has experienced a notable decline in its stock price, dropping by 15.61% over the past week. This movement comes amidst a series of analyst reports maintaining a ‘Hold ...

Docusign ( DOCU) shares sank 18% Friday, a day after the electronic signing software maker's billings missed estimates and it ...

On a year-to-date basis, DOCU has gained nearly 4 %, outperforming the broader S&P 500 Index, which rose 1.51% during the ...

Docusign DOCU will report first-quarter fiscal 2026 results on June 5, after market close. The Zacks Consensus Estimate for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign ...

The Stock Declines as the Truth is Revealed On May 16, 2025, the FDA published a briefing document stating that it doubted whether the submitted data was sufficient to conclude that UGN-102 was ...